453 related articles for article (PubMed ID: 9122233)
21. PML, a growth suppressor disrupted in acute promyelocytic leukemia.
Mu ZM; Chin KV; Liu JH; Lozano G; Chang KS
Mol Cell Biol; 1994 Oct; 14(10):6858-67. PubMed ID: 7935403
[TBL] [Abstract][Full Text] [Related]
22. The t(15;17) translocation in acute promyelocytic leukemia.
Lavau C; Jansen J; Dejean A
Pathol Biol (Paris); 1995 Mar; 43(3):188-96. PubMed ID: 7675545
[TBL] [Abstract][Full Text] [Related]
23. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.
Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ
Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585
[TBL] [Abstract][Full Text] [Related]
24. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
[TBL] [Abstract][Full Text] [Related]
25. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.
Zhang JW; Wang JY; Chen SJ; Chen Z
J Biosci; 2000 Sep; 25(3):275-84. PubMed ID: 11022230
[TBL] [Abstract][Full Text] [Related]
27. Retinoic acid receptors: involvement in acute promyelocytic leukemia.
Agadir A; Cornic M; Gourmel B; Lefebvre P; Degos L; Chomienne C
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):263-74. PubMed ID: 7920173
[TBL] [Abstract][Full Text] [Related]
28. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA.
Miller WH; Levine K; DeBlasio A; Frankel SR; Dmitrovsky E; Warrell RP
Blood; 1993 Sep; 82(6):1689-94. PubMed ID: 8400225
[TBL] [Abstract][Full Text] [Related]
29. The molecular biology of acute promyelocytic leukemia.
Slack JL; Gallagher RE
Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
[TBL] [Abstract][Full Text] [Related]
30. Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies.
Ablain J; Leiva M; Peres L; Fonsart J; Anthony E; de Thé H
J Exp Med; 2013 Apr; 210(4):647-53. PubMed ID: 23509325
[TBL] [Abstract][Full Text] [Related]
31. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML.
Kakizuka A; Miller WH; Umesono K; Warrell RP; Frankel SR; Murty VV; Dmitrovsky E; Evans RM
Cell; 1991 Aug; 66(4):663-74. PubMed ID: 1652368
[TBL] [Abstract][Full Text] [Related]
32. PML, PLZF and NPM genes in the molecular pathogenesis of acute promyelocytic leukemia.
Pandolfi PP
Haematologica; 1996; 81(5):472-82. PubMed ID: 8952164
[TBL] [Abstract][Full Text] [Related]
33. Differentiation response of acute promyelocytic leukemia cells and PML/RARa leukemogenic activity studies by real-time RT-PCR.
Caprodossi S; Pedinotti M; Amantini C; Santoni G; Minucci S; Pelicci PG; Fanelli M
Mol Biotechnol; 2005 Jul; 30(3):231-8. PubMed ID: 15988048
[TBL] [Abstract][Full Text] [Related]
34. A new variant translocation in acute promyelocytic leukaemia: molecular characterization and clinical correlation.
Wells RA; Hummel JL; De Koven A; Zipursky A; Kirby M; Dubé I; Kamel-Reid S
Leukemia; 1996 Apr; 10(4):735-40. PubMed ID: 8618456
[TBL] [Abstract][Full Text] [Related]
35. Pulsed-field gel electrophoresis analysis of retinoic acid receptor-alpha and promyelocytic leukemia rearrangements. Detection of the t(15;17) translocation in the diagnosis of acute promyelocytic leukemia.
Xiao YH; Miller WH; Warrell RP; Dmitrovsky E; Zelenetz AD
Am J Pathol; 1993 Nov; 143(5):1301-11. PubMed ID: 8238249
[TBL] [Abstract][Full Text] [Related]
36. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
[TBL] [Abstract][Full Text] [Related]
37. [Arsenic and retinoic acid, toward targeted treatments of acute promyelocytic anemia?].
de Thé H
C R Seances Soc Biol Fil; 1998; 192(2):273-81. PubMed ID: 9759370
[TBL] [Abstract][Full Text] [Related]
38. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells.
Weis K; Rambaud S; Lavau C; Jansen J; Carvalho T; Carmo-Fonseca M; Lamond A; Dejean A
Cell; 1994 Jan; 76(2):345-56. PubMed ID: 8293468
[TBL] [Abstract][Full Text] [Related]
40. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR.
de Thé H; Lavau C; Marchio A; Chomienne C; Degos L; Dejean A
Cell; 1991 Aug; 66(4):675-84. PubMed ID: 1652369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]